array(25) {
["id"]=>
string(5) "79752"
["name"]=>
string(9) "彭柔君"
["avatar"]=>
string(72) "https://img.39yst.com/uploads/19763/ac9271abb289c75b1defc0057ac83c50.jpg"
["status"]=>
string(1) "0"
["rank_type"]=>
string(1) "2"
["duodian_main_id"]=>
string(1) "0"
["miaopai"]=>
string(0) ""
["graphic_consult"]=>
string(1) "0"
["position"]=>
string(15) "副主任醫(yī)師"
["introduction"]=>
string(8527) "一、基本情況
綜合科主診教授,周一上午、周四下午門診。
?
二、教育及工作經(jīng)歷
2000年畢業(yè)于中山醫(yī)科大學(xué)臨床醫(yī)學(xué)系,獲學(xué)士學(xué)位
2007年畢業(yè)于中山大學(xué),獲腫瘤學(xué)碩士學(xué)位
2011年畢業(yè)于中山大學(xué),獲腫瘤學(xué)博士學(xué)位
2008年至2010年留學(xué)瑞典卡羅林斯卡醫(yī)學(xué)院,中-瑞聯(lián)合培養(yǎng)博士研究生
2000年7月至2015年7月,中山大學(xué)腫瘤防治中心內(nèi)科,從事惡性腫瘤內(nèi)科治療,住院醫(yī)師、主治醫(yī)師及副主任醫(yī)師
2015年8月至今,中山大學(xué)腫瘤防治中心綜合科,從事惡性腫瘤綜合治療,副主任醫(yī)師、主任醫(yī)師
2016年1月起聘任為中山大學(xué)碩士研究生導(dǎo)師、博士研究生導(dǎo)師
?
三、學(xué)術(shù)兼職
廣東省精準醫(yī)學(xué)應(yīng)用學(xué)會腫瘤綜合治療分會第一屆委員會主任委員
廣東省醫(yī)學(xué)會腫瘤精準診療分會第一屆常務(wù)委員
廣東省藥學(xué)會婦科腫瘤專家委員會常務(wù)委員
廣東省健康管理學(xué)會婦科腫瘤多學(xué)科協(xié)作專業(yè)委員會常務(wù)委員
廣東省健康管理學(xué)會委員常務(wù)委員
胸部腫瘤防治研究會乳腺癌專業(yè)委員會第一屆委員會常務(wù)委員
廣東省中西醫(yī)結(jié)合學(xué)會乳腺病專業(yè)委員會第一屆委員會常務(wù)委員
華南乳腺癌臨床研究協(xié)作組第一屆委員會秘書
吳階平基金會營養(yǎng)學(xué)部中西醫(yī)結(jié)合營養(yǎng)專業(yè)委員會第一屆常務(wù)委員
?
四、主持科研項目
國家自然科學(xué)基金面上項目、國家自然科學(xué)基金青年基金項目、廣東省自然科學(xué)面上項目、廣州市科技市科技計劃項目、中山大學(xué)高?;究蒲袠I(yè)務(wù)青年教師重點培育項目、吳階平醫(yī)學(xué)基金會臨床研究專項基金、中國抗癌協(xié)會橫向聯(lián)系基金、廣東省藥學(xué)會橫向聯(lián)系基金、中山大學(xué)腫瘤防治中心回國人員科研啟動基金等。
?
五、代表性論著
1. Yi-Qi Li, Chun-Ling Luo, Jia-Xin Jiang, Shuai He, Yang Liu, Wen-Xin Yan, Yi Xia, Qian Cui, Ying Huang, Jing Quan Lim, Dachuan Huang, Izzah Nabilah Hussein, Yan Gao, Guo-Wang Lin, Yi-Hong Ling, Dong Ma, Yue-Tong Zhang, Jason Yongsheng Chan, Pan-Pan Wei, Xiao-Xiao Wang, Chee Leong Cheng, Jie Xiong, Wei-Li Zhao, Choon Kiat Ong, Soon Thye Lim, Hui-Qiang Huang, Rou-Jun Peng*, and Jin-Xin Bei*. Single-Cell Analysis Reveals Malignant Cells Reshape the Cellular Landscape and Foster an Immunosuppressive Microenvironment of Extranodal NK/T-Cell Lymphoma. Adv Sci (Weinh). 2023 Dec;10(36): e2303913.
2.?Zhaohui Ruan#,?Yuetong Zhang#,?Zhaozhi Li#,?Jiaxin Jiang,?Wei Luo,?Qi Quan,?Zihao Xu,?Jinju Lei*,?Roujun Peng*. Characteristics and classification of first primary cancer patients with second primary cancer: a population-based cohort study. Clin Exp Med. 2023 Aug 9. doi: 10.1007/s10238-023-01149-3.
3. Zhaohui Ruan#, Qi Quan#, Qianyu Wang#, Jiaxin Jiang, Roujun Peng*. New Staging System and Prognostic Model for Malignant Phyllodes Tumor Patients without Distant?Metastasis: A Development and Validation Study.?J. Clin. Med.?2023, 12(5), 1889.
4. Wei Luo#, Qi Quan#, Jiaxin Jiang, Roujun Peng*. An immune and epithelial-mesenchymal transition-related risk model and immunotherapy strategy for grade II and III gliomas. Front Genet. 2023 Jan 4;13:1070630.
5. Zhaohui Ruan?#?,?Dongmei Chi?#?,?Qianyu Wang?,?Jiaxin Jiang?,?Qi Quan?,?Jinxin Bei?,?Roujun Peng*. Development and validation of a prognostic model and gene co-expression networks for breast carcinoma based on scRNA-seq and bulk-seq data. Ann Transl Med. 2022 Dec;10(24):1333.?
6. Zhaohui Ruan#,?Yuetong Zhang#,?Qi Quan?,?Jiaxin Jiang,?Qianyu Wang,?Yujing Zhang*,?Roujun Peng*. Pan-cancer analysis identifies DDX56 as a prognostic biomarker associated with immune infiltration and drug sensitivity. Front Genet. 2022 Dec 7;13:1004467.
7. Qianyu Wang#?,?Guifang Guo#,?Zhaohui Ruan?,?Huijiao Cao,?Ying Guo?,?Long Bai?,?Chang Jiang,?Shousheng Liu,?Wenzhuo He?,?Jinsheng Huang?,?Yuming Rong?,?Xuxian Chen,?Liangping Xia?,?Bei Zhang*?,?Roujun Peng*. Safety and Efficacy of Long-Term Zoledronic Acid in Advanced Breast Cancer with Bone Metastasis in South China. J Oncol. 2020 Sep 30;2020:5670601.
8. Roujun Peng#, Bowei Han#, Qingqing Cai#, Xiaoyu Zuo, Tao Xia, Jierong Chen, Lina Feng, Jingquan Lim, Shuwei Chen, Musheng Zeng, Yunmiao Guo, Bo Li, Xiaojun Xia, Yi Xia, Yurike Laurensia, Burton Kuan Hui Chia, Huiqiang Huang, Ken He Young, Soon Thye Lim, Choon Kiat Ong*, Yixin Zeng*, Jinxin Bei*; Genomic and transcriptomic landscapes of Epstein-Barr virus in extranodal natural killer T-cell lymphoma. Leukemia, 2019, 33(6):1451-1462.?
9. Haohua Wang#,?Roujun Peng#,?Xiuxing Chen,?Rui Jia,?Chunyue Huang,?Yuanyuan Huang,?Liangping Xia,?Guifang Guo. Effect of HK2, PKM2 and LDHA on Cetuximab efficacy in metastatic colorectal cancer. Oncol Lett. 2018 Apr;15(4):5553-5560.
10. Weicheng Ren#,?Xiaofei Ye#,?Hong Su,?Wei Li,?Dongbing Liu,?Mohammad Pirmoradian,?Xianhuo Wang,?Bo Zhang,?Qiang Zhang,?Longyun Chen,?Man Nie,?Yao Liu,?Bin Meng,?Huiqiang Huang,?Wenqi Jiang,?Yixin Zeng,?Wenyu Li,?Kui Wu,?Yong Hou,?Klas G Wiman,?Zhiming Li,?Huilai Zhang,?Roujun Peng#,?Shida Zhu#,?Qiang Pan-Hammarstr?m#. Genetic landscape of hepatitis B virus-associated diffuse large B-cell lymphoma. Blood.?2018, 131:2670-2681.
11. Zheng Li#,?Yi Xia#,?Li-Na Feng,?Jie-Rong Chen,?Hong-Min Li,?Jing Cui,?Qing-Qing Cai,?Kar Seng Sim,?Maarja-Liisa Nairism?gi,?Yurike Laurensia,?Wee Yang Meah,?Wen-Sheng Liu,?Yun-Miao Guo,?Li-Zhen Chen,?Qi-Sheng Feng,?Chi Pui Pang,?Li Jia Chen,?Soo Hong Chew,?Richard P Ebstein,?Jia Nee Foo,?Jianjun Liu,?Jeslin Ha,?Lay Poh Khoo,?Suk Teng Chin,?Yi-Xin Zeng,?Tin Aung,?Balram Chowbay,?Colin Phipps Diong,?Fen Zhang,?Yan-Hui Liu,?Tiffany Tang,?Miriam Tao,?Richard Quek,?Farid Mohamad,?Soo Yong Tan,?Bin Tean Teh,?Siok Bian Ng,?Wee Joo Chng,?Choon Kiat Ong,?Yukinori Okada,?Soumya Raychaudhuri,?Soon Thye Lim,?Wen Tan,?Rou-Jun Peng*,?Chiea Chuen Khor*,?Jin-Xin Bei*. Genetic risk of extranodal natural killer T-cell lymphoma: a genome-wide association study.?Lancet Oncol.?2016 Sep;17(9):1240-7.
12. Konstantinos Georgiou#,?Longyun Chen#,?Mattias Berglund,?Weicheng Ren,?Noel F C C de Miranda,?Susana Lisboa,?Marco Fangazio,?Shida Zhu,?Yong Hou,?Kui Wu,?Wenfeng Fang,?Xianhuo Wang,?Bin Meng,?Li Zhang,?Yixin Zeng,?Govind Bhagat,?Magnus Nordenskj?ld,?Christer Sundstr?m,?Gunilla Enblad,?Riccardo Dalla-Favera,?Huilai Zhang,?Manuel R Teixeira,?Laura Pasqualucci,?Roujun Peng*,?Qiang Pan-Hammarstr?m*. Genetic basis of PD-L1 overexpression in diffuse large B-cell lymphomas. Blood.?2016 Jun 16;127(24):3026-34.
13. Cong Xue#,?Roujun Peng#,?Ye Cao,?Shusen Wang,?Yanxia Shi,?Xin An,?Fei Xu,?Zhongyu Yuan*.?Ovarian Function, Not Age, Predicts the Benefit from Ovarian Suppression or Ablation for Premenopausal Women with Breast Cancer. PLoS One.?2016 Feb 11;11(2):e0148849.
14. de Miranda NF, Georgiou K, Chen L, Wu C, Gao Z, Zaravinos A, Lisboa S, Enblad G, Teixeira MR, Zeng Y, Peng R*, Pan-Hammarstr?m Q.?Exome sequencing reveals novel mutation targets in diffuse large B-cell lymphomas derived from Chinese patients.?Blood. 2014. 124(16):2544-53.
15. de Miranda NF,?Peng R#, Georgiou K, Wu C, Falk S?rqvist E, Berglund M, Chen L, Gao Z, Lagerstedt K, Lisboa S, Roos F, van Wezel T, Teixeira MR, Rosenquist R, Sundstr?m C, Enblad?G, Nilsson M, Zeng Y, Kipling D, Pan-Hammarstr?m Q. DNA repair genes are selectively mutated in diffuse large B cell lymphomas. J Exp Med. 2013. 210: 1729-42.
16. Du L, Peng RJ#, Bjorkman A, Filipe de Miranda N, Rosner C, Kotnis A, Berglund M, Liu C, Rosenquist R, Enblad G, Sundstrom C, Hojjat-Farsangi M, Rabbani H, Teixeira MR, Revy P, Durandy A, Zeng Y, Gennery AR, de Villartay JP, Pan-Hammarstrom Q. Cernunnos influences human immunoglobulin class switch recombination and may be associated with B cell lymphomagenesis. J Exp Med. 2012.209: 291-305.
17. Peng RJ#,?Huang ZF, Zhang YL, Yuan ZY, Xia Y, Jiang WQ, Zeng YX, Li J. 2011. Circulating and tumor-infiltrating Foxp3(+) regulatory T cell subset in Chinese patients with extranodal NK/T cell lymphoma. Int J Biol Sci 7: 1027-36.
18. Peng RJ#, Wang S, Shi Y, Liu D, Teng X, Qin T, Zeng Y, Yuan Z. 2011. Patients 35 years old or younger with operable breast cancer are more at risk for relapse and survival: a retrospective matched case-control study. Breast 20: 568-73.
?
?
?
?
?
更新時間:2024.06.07"
["adept"]=>
string(153) "長期從事惡性腫瘤綜合治療,擅長乳腺癌及婦科惡性腫瘤(卵巢癌、子宮內(nèi)膜癌、宮頸癌)的內(nèi)科治療和綜合治療。"
["duodian_doctor_id"]=>
string(6) "115111"
["source_from"]=>
string(12) "醫(yī)院官網(wǎng)"
["is_jingxuan"]=>
string(1) "0"
["title_num"]=>
string(0) ""
["created"]=>
string(10) "1754967836"
["doctor_title"]=>
string(15) "副主任醫(yī)師"
["is_seniority"]=>
int(1)
["province_id"]=>
int(0)
["city_id"]=>
int(0)
["hospital_sort"]=>
string(2) "32"
["hospital"]=>
array(1) {
[0]=>
array(29) {
["id"]=>
string(5) "19763"
["name"]=>
string(30) "中山大學(xué)腫瘤防治中心"
["grade_id"]=>
string(1) "2"
["grade"]=>
string(0) ""
["type"]=>
string(1) "1"
["duodian_hospital_id"]=>
string(3) "814"
["address"]=>
string(27) "廣州市東風(fēng)東路651號"
["is_gongli"]=>
string(1) "1"
["logo"]=>
string(72) "http://pic.39yst.com/group2/M00/8B/F7/Co2PPWKfAdKACBy1AABiOqd-PC074.jpeg"
["is_pay"]=>
string(1) "0"
["pic"]=>
string(72) "http://pic.39yst.com/group2/M00/99/67/Co2PPWZ-H3qABl2PAAK_8SuU6HY43.jpeg"
["is_top100"]=>
string(1) "1"
["parent_areaid"]=>
string(2) "19"
["areaid"]=>
string(4) "1601"
["top100_sort"]=>
string(2) "32"
["guide"]=>
string(0) ""
["tel"]=>
string(38) "020-87673713,020-87765368 "
["is_seniority"]=>
string(1) "1"
["hospital_title"]=>
string(6) "三甲"
["hospital_grade_id"]=>
string(1) "2"
["hospital_type"]=>
string(12) "綜合醫(yī)院"
["hospital_type_id"]=>
string(1) "1"
["hospital"]=>
string(30) "中山大學(xué)腫瘤防治中心"
["department_id"]=>
string(1) "0"
["duodian_department_id"]=>
string(6) "213424"
["duodian_department_pid"]=>
string(6) "213403"
["department_name"]=>
string(0) ""
["hospital_department"]=>
string(3) "科"
["duty"]=>
array(0) {
}
}
}
["version"]=>
int(40)
["isHaveSource"]=>
int(0)
["duty"]=>
string(0) ""
}